Event-Driven Stocks

ARTIVION, INC.

AORTNYSE

Healthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs6 gooddetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$441.3M$388.5M$354.0M$313.8M$298.8M$253.2M
Operating income$33.7M$38.9M$5.7M$6.2M$8.1M$2.4M
Net income$9.8M−$13.4M−$30.7M−$19.2M−$14.8M−$16.7M
Total assets$884.8M$789.1M$792.4M$762.8M$793.1M$789.4M
Total liabilities$436.6M$512.9M$510.6M$478.5M$492.3M$460.7M
Equity$448.2M$276.2M$281.8M$284.3M$300.7M$328.7M
EPS (diluted)$0.21$-0.32$-0.75$-0.48$-0.38$-0.44
Shares out.42.0M41.2M40.6M40.1M39.0M39.1M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
7.6%
Net margin
2.2%
Return on equity
2.2%
Return on assets
1.1%
Return on capital (ROCE)
4.3%
Liabilities / assets
49.3%
Debt / equity
0.97×
Book value / share
$10.66
Revenue growth (YoY)
13.6%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
3.05safe
Accruals / assets
3.4%clean
Beneish M-Score
-2.44normal
Piotroski F-Score
6/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
93
/ 100
Profitability 100Growth 100Catalyst 67Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

6 good
  • Operating margin is positive
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20261.9M1.7+1.1%
Apr 30, 20261.9M6.3-1.2%
Apr 15, 20261.9M3.7+16.6%
Mar 31, 20261.7M4.3-0.4%
Mar 13, 20261.7M4.2+6.3%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.